Skip to content
Boost Up Blog – Lifestyle
Author:
Elanco Animal Health
Elanco Releases 2025 Impact Report, Demonstrating How Animal Health Helps Meet Society’s Growing Needs
July 31, 2026
Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Kills Ticks¹ Faster² than Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) and NexGard® Plus (afoxolaner, moxidectin, and pyrantel chewable tablets)
July 22, 2026
Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement
July 8, 2026
Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health
June 18, 2026
Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs
June 15, 2026
Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World Screwworm
June 4, 2026
New Research Reveals Pet Spending as a “Protected Budget Item” for Owners, Fueling Industry Resilience
June 3, 2026
Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market
May 21, 2026
Elanco to Participate in Upcoming Investor Conferences
May 21, 2026
Elanco Animal Health Reports First Quarter 2026 Results
May 6, 2026
1
2
Next Page
→